A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

  1. van Brummelen, E.M.J.
  2. Levchenko, E.
  3. Dómine, M.
  4. Fennell, D.A.
  5. Kindler, H.L.
  6. Viteri, S.
  7. Gadgeel, S.
  8. López, P.G.
  9. Kostorov, V.
  10. Morgensztern, D.
  11. Orlov, S.
  12. Zauderer, M.G.
  13. Vansteenkiste, J.F.
  14. Baker-Neblett, K.
  15. Vasquez, J.
  16. Wang, X.
  17. Bellovin, D.I.
  18. Schellens, J.H.M.
  19. Yan, L.
  20. Mitrica, I.
  21. DeYoung, M.P.
  22. Trigo, J.
Revue:
Investigational New Drugs

ISSN: 1573-0646 0167-6997

Année de publication: 2020

Volumen: 38

Número: 2

Pages: 457-467

Type: Article

DOI: 10.1007/S10637-019-00783-7 GOOGLE SCHOLAR